{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:14:04Z","timestamp":1759331644379,"version":"build-2065373602"},"reference-count":93,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017091","name":"Sumitomo Chemical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017091","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.yrtph.2025.105929","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T01:19:51Z","timestamp":1755739191000},"page":"105929","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Mode of action analysis for mouse liver tumor formation by MGK-264 and human relevance"],"prefix":"10.1016","volume":"163","author":[{"given":"Junji","family":"Yano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kensuke","family":"Kawamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukako","family":"Shimotsuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Matsunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoki","family":"Fukunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas G.","family":"Osimitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian G.","family":"Lake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Asano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yrtph.2025.105929_bib1","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/toxsci\/kfy149","article-title":"Role of YAP activation in nuclear receptor CAR-mediated proliferation of mouse hepatocytes","volume":"165","author":"Abe","year":"2018","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2025.105929_bib2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0022-3476(80)80123-5","article-title":"The effects of phenobarbital and diphenylhydantoin on liver function and morphology","volume":"97","author":"Aiges","year":"1980","journal-title":"J. Pediatr."},{"key":"10.1016\/j.yrtph.2025.105929_bib3","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.31521","article-title":"Yes-associated protein is crucial for constitutive androstane receptor-driven hepatocyte proliferation but not for induction of drug metabolism genes in mice","volume":"73","author":"Bhushan","year":"2021","journal-title":"Hepatology"},{"year":"1987","series-title":"13 Week Dietary Range-Finding Toxicity Study in Mice with MGK-264 Insecticide Synergist (Stdy No. 551-010)","author":"Blair","key":"10.1016\/j.yrtph.2025.105929_bib4"},{"year":"1991","series-title":"Eighteen Month Dietary Oncogenicity Study in Mice with MGK-264 Insecticide Synergist (Study No. 551-011)","author":"Blair","key":"10.1016\/j.yrtph.2025.105929_bib5"},{"key":"10.1016\/j.yrtph.2025.105929_bib6","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1080\/10408440600977677","article-title":"IPCS framework for analyzing the relevance of a cancer mode of action for humans","volume":"36","author":"Boobis","year":"2006","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105929_bib7","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/10408440701749421","article-title":"IPCS framework for analyzing the relevance of a noncancer mode of action for humans","volume":"38","author":"Boobis","year":"2008","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105929_bib8","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1007\/s00204-020-02935-8","article-title":"beta-catenin signaling, the constitutive androstane receptor and their mutual interactions","volume":"94","author":"Braeuning","year":"2020","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105929_bib9","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/toxsci\/23.2.280","article-title":"Carcinogenicity studies of oxazepam in mice","volume":"23","author":"Bucher","year":"1994","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2025.105929_bib10","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1177\/0192623310363813","article-title":"Evaluation of possible carcinogenic risk to humans based on liver tumors in rodent assays: the two-year bioassay is no longer necessary","volume":"38","author":"Cohen","year":"2010","journal-title":"Toxicol. Pathol."},{"issue":"Suppl. 1","key":"10.1016\/j.yrtph.2025.105929_bib11","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1093\/toxsci\/kfq365","article-title":"Chemical carcinogenesis","volume":"120","author":"Cohen","year":"2011","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2025.105929_bib12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/toxsci\/kfh073","article-title":"Evaluating the human relevance of chemically induced animal tumors","volume":"78","author":"Cohen","year":"2004","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2025.105929_bib13","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1080\/713608371","article-title":"The human relevance of information on carcinogenic modes of action: overview","volume":"33","author":"Cohen","year":"2003","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105929_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10408444.2013.835784","article-title":"Mode of action framework analysis for receptor-mediated toxicity: the peroxisome proliferator-activated receptor alpha (PPARalpha) as a case study","volume":"44","author":"Corton","year":"2014","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105929_bib15","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00204-017-2094-7","article-title":"The PPARalpha-dependent rodent liver tumor response is not relevant to humans: addressing misconceptions","volume":"92","author":"Corton","year":"2018","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105929_bib93","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1038\/s41467-025-56642-y","article-title":"The hypolipidemic effect of MI-883, the combined CAR agonist\/ PXR antagonist, in diet-induced hypercholesterolemia model","volume":"16","author":"Dusek","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.yrtph.2025.105929_bib16","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1177\/01926233211027474","article-title":"Chimeric mouse with humanized liver is an appropriate animal model to investigate mode of action for porphyria-mediated hepatocytotoxicity","volume":"49","author":"Eguchi","year":"2021","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.yrtph.2025.105929_bib17","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3109\/10408444.2013.835786","article-title":"Mode of action and human relevance analysis for nuclear receptor-mediated liver toxicity: a case study with phenobarbital as a model constitutive androstane receptor (CAR) activator","volume":"44","author":"Elcombe","year":"2014","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105929_bib18","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1002\/ijc.24545","article-title":"Epidemiologic evaluation of pharmaceuticals with limited evidence of carcinogenicity","volume":"125","author":"Friedman","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.yrtph.2025.105929_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2022.105268","article-title":"Evaluation of the mode of action and human relevance of liver tumors in male mice treated with epyrifenacil","volume":"136","author":"Fukunaga","year":"2022","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2025.105929_bib20","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1080\/019262301753385979","article-title":"Review article: compendium of chemical carcinogens by target organ: results of chronic bioassays in rats, mice, hamsters, dogs, and monkeys","volume":"29","author":"Gold","year":"2001","journal-title":"Toxicol. Pathol."},{"year":"1993","series-title":"24 Month Chronic Toxicity and Oncogenicity Study in the Rat with MGK-264 (Study No. 552-030)","author":"Goldenthal","key":"10.1016\/j.yrtph.2025.105929_bib21"},{"key":"10.1016\/j.yrtph.2025.105929_bib22","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1006\/faat.1996.0016","article-title":"Biochemical effects of the mouse hepatocarcinogen oxazepam: similarities to phenobarbital","volume":"29","author":"Griffin","year":"1996","journal-title":"Fund. Appl. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105929_bib23","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1007\/s00204-020-02936-7","article-title":"Inhibition and induction of CYP enzymes in humans: an update","volume":"94","author":"Hakkola","year":"2020","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105929_bib24","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1177\/0192623312448935","article-title":"Liver hypertrophy: a review of adaptive (adverse and non-adverse) changes--conclusions from the 3rd International ESTP Expert Workshop","volume":"40","author":"Hall","year":"2012","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.yrtph.2025.105929_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2023.116439","article-title":"Novel approach for verification of a human PBPK modeling strategy using chimeric mice in the health risk assessment of epyrifenacil","volume":"465","author":"Hirasawa","year":"2023","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.yrtph.2025.105929_bib26","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.tox.2009.01.007","article-title":"Comparison of the effects of the synthetic pyrethroid Metofluthrin and phenobarbital on CYP2B form induction and replicative DNA synthesis in cultured rat and human hepatocytes","volume":"258","author":"Hirose","year":"2009","journal-title":"Toxicology"},{"key":"10.1016\/j.yrtph.2025.105929_bib27","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/toxsci\/kfj001","article-title":"Mode of action in relevance of rodent liver tumors to human cancer risk","volume":"89","author":"Holsapple","year":"2006","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2025.105929_bib28","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1289\/ehp.9193247","article-title":"Chemicals associated with site-specific neoplasia in 1394 long-term carcinogenesis experiments in laboratory rodents","volume":"93","author":"Huff","year":"1991","journal-title":"Environ. Health Perspect."},{"year":"2001","series-title":"IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 79. Some Thyrotropic Agents","key":"10.1016\/j.yrtph.2025.105929_bib29"},{"key":"10.1016\/j.yrtph.2025.105929_bib30","article-title":"Is long-term use of benzodiazepine a risk for cancer?","volume":"94","author":"Iqbal","year":"2015","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.yrtph.2025.105929_bib31","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1124\/dmd.118.080770","article-title":"Transport kinetics, selective inhibition, and successful prediction of in vivo inhibition of rat hepatic organic anion transporting polypeptides","volume":"46","author":"Ishida","year":"2018","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.yrtph.2025.105929_bib32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.toxlet.2012.08.001","article-title":"Chimeric mice with a humanized liver as an animal model of troglitazone-induced liver injury","volume":"214","author":"Kakuni","year":"2012","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.yrtph.2025.105929_bib33","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3390\/ijms15010058","article-title":"Chimeric mice with humanized livers: a unique tool for in vivo and in vitro enzyme induction studies","volume":"15","author":"Kakuni","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yrtph.2025.105929_bib34","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/0006-2952(89)90192-5","article-title":"Induction of cytochrome P450IA1 in mouse hepatoma cells by several chemicals: phenobarbital and TCDD induce the same form of cytochrome P450","volume":"38","author":"K\u00e4renlampi","year":"1989","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.yrtph.2025.105929_bib35","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1080\/10408444.2024.2377208","article-title":"Mode of action of dieldrin-induced liver tumors: application to human risk assessment","volume":"54","author":"Klaunig","year":"2024","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105929_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/CEJ.0b013e32836014c8","article-title":"A review of epidemiological data on epilepsy, phenobarbital, and risk of liver cancer","volume":"23","author":"La Vecchia","year":"2014","journal-title":"Eur. J. Cancer Prev."},{"key":"10.1016\/j.yrtph.2025.105929_bib37","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1080\/00498250903098184","article-title":"Species differences in the hepatic effects of inducers of CYP2B and CYP4A subfamily forms: relationship to rodent liver tumour formation","volume":"39","author":"Lake","year":"2009","journal-title":"Xenobiotica"},{"key":"10.1016\/j.yrtph.2025.105929_bib38","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1039\/c8tx00008e","article-title":"Human relevance of rodent liver tumour formation by constitutive androstane receptor (CAR) activators","volume":"7","author":"Lake","year":"2018","journal-title":"Toxicol. Res."},{"key":"10.1016\/j.yrtph.2025.105929_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2020.152465","article-title":"Piperonyl butoxide: mode of action analysis for mouse liver tumour formation and human relevance","volume":"439","author":"Lake","year":"2020","journal-title":"Toxicology"},{"key":"10.1016\/j.yrtph.2025.105929_bib40","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.toxrep.2017.10.007","article-title":"Integration of novel approaches demonstrates simultaneous metabolic inactivation and CAR-mediated hepatocarcinogenesis of a nitrification inhibitor","volume":"4","author":"LaRocca","year":"2017","journal-title":"Toxicol. Rep."},{"issue":"Suppl. 2","key":"10.1016\/j.yrtph.2025.105929_bib41","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3109\/10408444.2014.910751","article-title":"Human relevance framework for rodent liver tumors induced by the insecticide sulfoxaflor","volume":"44","author":"LeBaron","year":"2014","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105929_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.101885","article-title":"Human constitutive androstane receptor represses liver cancer development and hepatoma cell proliferation by inhibiting erythropoietin signaling","volume":"298","author":"Li","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yrtph.2025.105929_bib43","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1194\/jlr.M800226-JLR200","article-title":"The nuclear receptor CAR (NR1I3) regulates serum triglyceride levels under conditions of metabolic stress","volume":"50","author":"Maglich","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.yrtph.2025.105929_bib44","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1124\/mol.62.3.638","article-title":"Nuclear pregnane X receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification","volume":"62","author":"Maglich","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.yrtph.2025.105929_bib45","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1517\/17425255.2.6.875","article-title":"Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction","volume":"2","author":"Martignoni","year":"2006","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105929_bib46","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1016\/j.ajpath.2018.07.022","article-title":"High frequency of beta-catenin mutations in mouse hepatocellular carcinomas induced by a nongenotoxic constitutive androstane receptor agonist","volume":"188","author":"Mattu","year":"2018","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.yrtph.2025.105929_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jat.2949","article-title":"New developments in the evolution and application of the WHO\/IPCS framework on mode of action\/species concordance analysis","volume":"34","author":"Meek","year":"2014","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105929_bib48","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1080\/713608373","article-title":"A framework for human relevance analysis of information on carcinogenic modes of action","volume":"33","author":"Meek","year":"2003","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105929_bib49","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1080\/713608373","article-title":"A framework for human relevance analysis of information on carcinogenic modes of action","volume":"33","author":"Meek","year":"2008","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105929_bib50","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jat.2984","article-title":"Mode of action human relevance (species concordance) framework: evolution of the Bradford Hill considerations and comparative analysis of weight of evidence","volume":"34","author":"Meek","year":"2014","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105929_bib51","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1006\/rtph.1993.1048","article-title":"The paradoxical lack of interspecies correlation between plasma concentrations and chemical carcinogenicity","volume":"18","author":"Monro","year":"1993","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2025.105929_bib52","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.dmpk.2017.11.001","article-title":"Chimeric mice with humanized liver: application in drug metabolism and pharmacokinetics studies for drug discovery","volume":"33","author":"Naritomi","year":"2018","journal-title":"Drug Metabol. Pharmacokinet."},{"key":"10.1016\/j.yrtph.2025.105929_bib53","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/toxsci\/kfy228","article-title":"Chimeric mice with humanized livers demonstrate human-specific hepatotoxicity caused by a therapeutic antibody against TRAIL-receptor 2\/death receptor 5","volume":"167","author":"Nihira","year":"2019","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2025.105929_bib54","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1039\/C7TX00163K","article-title":"Candidate genes responsible for early key events of phenobarbital-promoted mouse hepatocellular tumorigenesis based on differentiation of regulating genes between wild type mice and humanized chimeric mice","volume":"6","author":"Ohara","year":"2017","journal-title":"Toxicol. Res."},{"key":"10.1016\/j.yrtph.2025.105929_bib55","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2131\/jts.48.99","article-title":"Establishment of hyperoxic cell culture system for predicting drug-induced liver injury: reducing accumulated lipids in hepatocytes derived from chimeric mice with humanized liver","volume":"48","author":"Ohtsuki","year":"2023","journal-title":"J. Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2025.105929_bib56","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2131\/jts.42.773","article-title":"Evaluation of the human relevance of the constitutive androstane receptor-mediated mode of action for rat hepatocellular tumor formation by the synthetic pyrethroid momfluorothrin","volume":"42","author":"Okuda","year":"2017","journal-title":"J. Toxicol. Sci."},{"issue":"Suppl. 1","key":"10.1016\/j.yrtph.2025.105929_bib57","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1093\/toxsci\/kfq338","article-title":"Xenobiotic metabolism, disposition, and regulation by receptors: from biochemical phenomenon to predictors of major toxicities","volume":"120","author":"Omiecinski","year":"2011","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2025.105929_bib58","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.taap.2004.01.010","article-title":"The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes","volume":"199","author":"Parkinson","year":"2004","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.yrtph.2025.105929_bib59","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.yrtph.2018.04.001","article-title":"Minimum datasets to establish a CAR-mediated mode of action for rodent liver tumors","volume":"96","author":"Peffer","year":"2018","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2025.105929_bib60","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF03189387","article-title":"Influence of liver size on the relationship between in vivo and in vitro studies of drug metabolism","volume":"3","author":"Pirttiaho","year":"1978","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.yrtph.2025.105929_bib61","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/BF00542550","article-title":"Hepatic blood flow and drug metabolism in patients on enzyme-inducing anticonvulsants","volume":"22","author":"Pirttiaho","year":"1982","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.yrtph.2025.105929_bib62","first-page":"27","article-title":"Synergists as research tools and control agents in agriculture","volume":"2","author":"Raffa","year":"1985","journal-title":"J. Agric. Entomol."},{"key":"10.1016\/j.yrtph.2025.105929_bib63","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1177\/0192623313482055","article-title":"Different pathways of constitutive androstane receptor-mediated liver hypertrophy and hepatocarcinogenesis in mice treated with piperonyl butoxide or decabromodiphenyl ether","volume":"41","author":"Sakamoto","year":"2013","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.yrtph.2025.105929_bib64","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1177\/0192623308318212","article-title":"Human hepatocytes can repopulate mouse liver: histopathology of the liver in human hepatocyte-transplanted chimeric mice and toxicologic responses to acetaminophen","volume":"36","author":"Sato","year":"2008","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.yrtph.2025.105929_bib65","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1172\/JCI35483","article-title":"A novel panel of mouse models to evaluate the role of human pregnane X receptor and constitutive androstane receptor in drug response","volume":"118","author":"Scheer","year":"2008","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.yrtph.2025.105929_bib66","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0378-4274(82)90113-8","article-title":"Spontaneous tumors in control F344 and charles river-CD rats and charles river CD-1 and B6C3HF1 mice","volume":"11","author":"Sher","year":"1982","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.yrtph.2025.105929_bib67","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/toxsci\/kfad129","article-title":"Interaction with YAP underlies the species differences between humans and rodents in CAR-dependent hepatocyte proliferation","volume":"198","author":"Shizu","year":"2024","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2025.105929_bib68","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1080\/17425255.2020.1746268","article-title":"Nuclear receptor CAR-mediated liver cancer and its species differences","volume":"16","author":"Shizu","year":"2020","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105929_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2019.152343","article-title":"Analysis of beta-catenin gene mutations and gene expression in liver tumours of C57BL\/10J mice produced by chronic administration of sodium phenobarbital","volume":"430","author":"Sidaway","year":"2020","journal-title":"Toxicology"},{"key":"10.1016\/j.yrtph.2025.105929_bib70","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1073\/pnas.92.4.959","article-title":"A single arginine residue determines species specificity of the human growth hormone receptor","volume":"92","author":"Souza","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yrtph.2025.105929_bib71","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1007\/s00204-022-03338-7","article-title":"Proteomic analysis of hepatic effects of phenobarbital in mice with humanized liver","volume":"96","author":"Sprenger","year":"2022","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105929_bib72","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1007\/s00415-020-10379-4","article-title":"Anti-seizure medication is not associated with an increased risk to develop cancer in epilepsy patients","volume":"268","author":"Stritzelberger","year":"2021","journal-title":"J. Neurol."},{"key":"10.1016\/j.yrtph.2025.105929_bib73","article-title":"Weight of evidence and human relevance evaluation of the benfluralin mode of action in rodents (Part I): liver carcinogenesis","volume":"117","author":"Strupp","year":"2020","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2025.105929_bib74","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1021\/mp9001552","article-title":"Transcriptional activation of PPAR\u03b1 by phenobarbital in the absence of CAR and PXR","volume":"6","author":"Tamasi","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.yrtph.2025.105929_bib75","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1210\/en.2010-0953","article-title":"Growth hormone-dependent pathogenesis of human hepatic steatosis in a novel mouse model bearing a human hepatocyte-repopulated liver","volume":"152","author":"Tateno","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.yrtph.2025.105929_bib76","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0002-9440(10)63352-4","article-title":"Near completely humanized liver in mice shows human-type metabolic responses to drugs","volume":"165","author":"Tateno","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.yrtph.2025.105929_bib77","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1293\/tox.25.189","article-title":"Comparative histomorphological review of rat and human hepatocellular proliferative lesions","volume":"25","author":"Thoolen","year":"2012","journal-title":"J. Toxicol. Pathol."},{"key":"10.1016\/j.yrtph.2025.105929_bib78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/mol.61.1.1","article-title":"Diverse roles of the nuclear orphan receptor CAR in regulating hepatic genes in response to phenobarbital","volume":"61","author":"Ueda","year":"2002","journal-title":"Mol. Pharmacol."},{"year":"1995","series-title":"Memorandum: Carcinogenicity Peer Review for MGK-264","key":"10.1016\/j.yrtph.2025.105929_bib79"},{"journal-title":"HED Guidance Document # G2002.01","article-title":"Hepatocellular hypertrophy","year":"2002","key":"10.1016\/j.yrtph.2025.105929_bib80"},{"year":"2005","series-title":"Guidelines for Carcinogen Risk Assessment. EPA\/630\/P-03\/001F","key":"10.1016\/j.yrtph.2025.105929_bib81"},{"year":"2006","series-title":"Reregistration Eligibility Decision for N-Octyl Bicycloheptene Dicarboximide (MGK-264). EPA 738-R-06-006","key":"10.1016\/j.yrtph.2025.105929_bib82"},{"year":"2024","series-title":"MGK-264: Cancer Reassessment of the Cancer Assessment Review Committee. MRID #5179401","key":"10.1016\/j.yrtph.2025.105929_bib83"},{"key":"10.1016\/j.yrtph.2025.105929_bib84","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0304-3835(97)00229-2","article-title":"Chemicals with carcinogenic activity in the rodent liver; mechanistic evaluation of human risk","volume":"117","author":"Williams","year":"1997","journal-title":"Cancer Lett."},{"key":"10.1016\/j.yrtph.2025.105929_bib85","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1039\/c7tx00288b","article-title":"Case examples of an evaluation of the human relevance of the pyrethroids\/pyrethrins-induced liver tumours in rodents based on the mode of action","volume":"7","author":"Yamada","year":"2018","journal-title":"Toxicol. Res."},{"key":"10.1016\/j.yrtph.2025.105929_bib86","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1293\/tox.2021-0027","article-title":"Application of humanized mice to toxicology studies: evaluation of the human relevance of the mode of action for rodent liver tumor formation by activators of the constitutive androstane receptor (CAR)","volume":"34","author":"Yamada","year":"2021","journal-title":"J. Toxicol. Pathol."},{"key":"10.1016\/j.yrtph.2025.105929_bib87","first-page":"1","article-title":"Critical evaluation of the human relevance of the mode of action for rodent liver tumor formation by activators of the constitutive androstane receptor (CAR)","author":"Yamada","year":"2021","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105929_bib88","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1039\/C4TX00217B","article-title":"Lack of effect of metofluthrin and sodium phenobarbital on replicative DNA synthesis and Ki-67 mRNA expression in cultured human hepatocytes","volume":"4","author":"Yamada","year":"2015","journal-title":"Toxicology Research"},{"key":"10.1016\/j.yrtph.2025.105929_bib89","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/toxsci\/kfaa125","article-title":"Comparison of the hepatic effects of phenobarbital in chimeric mice containing either rat or human hepatocytes with humanized constitutive androstane receptor and pregnane X receptor mice","volume":"177","author":"Yamada","year":"2020","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2025.105929_bib90","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/toxsci\/kfu173","article-title":"Human hepatocytes support the hypertrophic but not the hyperplastic response to the murine nongenotoxic hepatocarcinogen sodium phenobarbital in an in vivo study using a chimeric mouse with humanized liver","volume":"142","author":"Yamada","year":"2014","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2025.105929_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2025.105834","article-title":"Mode of action analysis for rat thyroid gland follicular cell tumor formation by MGK-264 and human relevance","volume":"160","author":"Yano","year":"2025","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2025.105929_bib92","series-title":"Cytochromes P450: Role in the Metabolism and Toxicity of Drugs and Other Xenobiotics","first-page":"417","article-title":"Receptor-mediated regulation of cytochromes P450","author":"Yoshinari","year":"2008"}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230025001618?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230025001618?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:11:40Z","timestamp":1759259500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230025001618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":93,"alternative-id":["S0273230025001618"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2025.105929","relation":{},"ISSN":["0273-2300"],"issn-type":[{"type":"print","value":"0273-2300"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mode of action analysis for mouse liver tumor formation by MGK-264 and human relevance","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2025.105929","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"105929"}}